Gerstein HC, et al: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
With clinician guidance, patients can safely plan pregnancy, pause treatment appropriately, and maintain long-term health
Many patients notice a reduction in appetite within the first 12 weeks
Some people might experience a noticeable boost in energy quite quickly, while others might take a bit longer to feel the full effects
As a result, this blend serves as an ideal model for comprehensive regenerative and cosmetic science investigations
For most patients, when used under strict medical supervision, the answer is yes